世界睡眠医学杂志
世界睡眠醫學雜誌
세계수면의학잡지
2014年
5期
284-286
,共3页
瑞波西汀%帕罗西汀%抑郁症
瑞波西汀%帕囉西汀%抑鬱癥
서파서정%파라서정%억욱증
Reboxetine%Paroxetine%Depression
目的:比较瑞波西汀与帕罗西汀治疗抑郁症的疗效和安全性。方法将84例抑郁症患者按照随机数字表随机分为2组各42例,瑞波西汀组给予瑞波西汀,初始剂量4 mg /d,2周内渐增至12 mg /d;帕罗西汀组给予帕罗西汀,初始剂量20 mg /d,2周内渐增至50 mg /d,疗程均为6周。采用汉密尔顿抑郁量表(HAMD)评定临床疗效,不良反应量表(TESS)评定不良反应。结果瑞波西汀组有效率为88.0%、显效率为76.1%;帕罗西汀组有效率为90.4%、显效率为78.5%,2组显效率比较差异无统计学意义(P >0.05)。结论瑞波西汀与帕罗西汀治疗抑郁症均有疗,依从性好,且瑞波西汀起效较帕罗西汀快。
目的:比較瑞波西汀與帕囉西汀治療抑鬱癥的療效和安全性。方法將84例抑鬱癥患者按照隨機數字錶隨機分為2組各42例,瑞波西汀組給予瑞波西汀,初始劑量4 mg /d,2週內漸增至12 mg /d;帕囉西汀組給予帕囉西汀,初始劑量20 mg /d,2週內漸增至50 mg /d,療程均為6週。採用漢密爾頓抑鬱量錶(HAMD)評定臨床療效,不良反應量錶(TESS)評定不良反應。結果瑞波西汀組有效率為88.0%、顯效率為76.1%;帕囉西汀組有效率為90.4%、顯效率為78.5%,2組顯效率比較差異無統計學意義(P >0.05)。結論瑞波西汀與帕囉西汀治療抑鬱癥均有療,依從性好,且瑞波西汀起效較帕囉西汀快。
목적:비교서파서정여파라서정치료억욱증적료효화안전성。방법장84례억욱증환자안조수궤수자표수궤분위2조각42례,서파서정조급여서파서정,초시제량4 mg /d,2주내점증지12 mg /d;파라서정조급여파라서정,초시제량20 mg /d,2주내점증지50 mg /d,료정균위6주。채용한밀이돈억욱량표(HAMD)평정림상료효,불량반응량표(TESS)평정불량반응。결과서파서정조유효솔위88.0%、현효솔위76.1%;파라서정조유효솔위90.4%、현효솔위78.5%,2조현효솔비교차이무통계학의의(P >0.05)。결론서파서정여파라서정치료억욱증균유료,의종성호,차서파서정기효교파라서정쾌。
Objective To compare the clinical efficacy and safety of of reboxetine vs.paroxet ine in the treatment o f depression.Methods 84 patients were randomly divided into reboxe tine (n =42)and paroxetine (n =42)group for 6 weeks. The efficacy and side effects were assessed with the Hamilton Depression Rating Scale (HAMD)and Treatment Emergent Symp-tom Scale (TESS),respect ively.Results The total efficiency in reboxetine group and paroxetineinthe group were88.0% and 90.4% respectively,and no significant difference between two groups(P >0.05).Conclusion Both reboxetine and paroxetine have evident effects,higher safety and better compliance in the treatment of depression,but the former shows a faster effect.